Available FDA-approved medications for the prevention of osteoporosis in postmenopausal women*

Drug class	Medication	Dose
Estrogens	Many	Variable
Bisphosphonates	Alendronate	35 mg/week or 5 mg/day
	Risedronate	35 mg/week, 5 mg/day, or 150 mg/month
	Ibandronate	150 mg/month
	Zoledronic acid	5 mg IV once every two years
Selective estrogen receptor modulators (SERMs)	Raloxifene	60 mg/day
Selective estrogen receptor modulators (SERMs)	Bazedoxifene - conjugated equine estrogen	20 mg/0.45 mg daily

FDA: US Food and Drug Administration; IV: intravenous.
* There are no FDA-approved medications for prevention of osteoporosis in men.

Graphic 64685 Version 8.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟